FR2916971A1 - Slimming kit, useful for slim the body to treat bags under the eyes, comprises substrate comprising biocellulose, and composition impregnating the substrate, comprising active slimming agent containing e.g. caffeine and its derivatives - Google Patents
Slimming kit, useful for slim the body to treat bags under the eyes, comprises substrate comprising biocellulose, and composition impregnating the substrate, comprising active slimming agent containing e.g. caffeine and its derivatives Download PDFInfo
- Publication number
- FR2916971A1 FR2916971A1 FR0755532A FR0755532A FR2916971A1 FR 2916971 A1 FR2916971 A1 FR 2916971A1 FR 0755532 A FR0755532 A FR 0755532A FR 0755532 A FR0755532 A FR 0755532A FR 2916971 A1 FR2916971 A1 FR 2916971A1
- Authority
- FR
- France
- Prior art keywords
- derivatives
- substrate
- caffeine
- extracts
- slimming
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9741—Pteridophyta [ferns]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
La présente invention concerne les compositions et ensembles amincissants.The present invention relates to slimming compositions and sets.
De nombreuses publications divulguent des compositions amincissantes, par exemple EP 0 493 151 ou WO 02/066000. Par ailleurs, un certain nombre d'articles à disposer autour du corps afin d'exercer une action amincissante ont déjà été proposés. Les brevets FR 2 119 105, FR 2 051 052, FR 1 559 230 et FR 1 525 914 divulguent des bandes élastiques amincissantes. Le brevet US 4 946 453 décrit un vêtement amincissant en Néoprène Lycra . Numerous publications disclose slimming compositions, for example EP 0 493 151 or WO 02/066000. In addition, a number of articles to be arranged around the body in order to exert a slimming action have already been proposed. The patents FR 2 119 105, FR 2 051 052, FR 1 559 230 and FR 1 525 914 disclose elastic slimming bands. US Patent 4,946,453 discloses a thin Lycra Neoprene garment.
La demande de brevet FR 2 865 905 divulgue un vêtement de sport destiné à lutter contre la cellulite, comportant des substances actives microencapsulées. La technique de microencapsulation est relativement complexe à mettre en oeuvre et de plus, une fois les actifs libérés, le vêtement perd en efficacité. Le brevet US 4 829 987 divulgue un procédé pour lutter contre la cellulite et maigrir, dans lequel l'utilisateur s'enroule avant une séance d'exercice physique d'un bandage élastique qui est imprégné d'une solution minérale. Un tel procédé est réservé à une activité au cours de laquelle l'utilisateur peut ne pas avoir de vêtements recouvrant la région entourée par le bandage ou peut tolérer d'avoir les vêtements éventuels mouillés par la solution minérale imprégnant le bandage. The patent application FR 2 865 905 discloses a sportswear intended to fight against cellulite, comprising microencapsulated active substances. The microencapsulation technique is relatively complex to implement and moreover, once the assets released, the garment loses effectiveness. US Pat. No. 4,829,987 discloses a method for combating cellulite and losing weight, in which the user wraps himself before an exercise session with an elastic bandage which is impregnated with a mineral solution. Such a method is reserved for an activity in which the user may not have clothing covering the region surrounded by the bandage or may tolerate having the possible clothing wetted by the mineral solution impregnating the bandage.
De nombreuses compositions amincissantes sont connues, ayant par exemple une action drainante, c'est-à-dire réduisant la rétention d'eau dans l'épiderme et/ou le derme superficiel, et/ou agissant en limitant la lipogénèse ou en favorisant la lipolyse. Il existe un besoin pour renforcer l'action des compositions amincissantes. L'invention y parvient, selon l'un de ses aspects, grâce à un ensemble 25 amincissant comportant : - un substrat comportant de la biocellulose, - une composition comportant un actif amincissant, imprégnant le substrat. L'actif amincissant est choisi parmi la caféine et ses dérivés, le citrate de caféine, la théophylline et ses dérivés, la théobromine, l' acéfylline, l'aminophylline, la 30 chloroéthylthéophylline, le diprofylline, le diniprophylline, l'étamiphylline et ses dérivés, l'étofylline, la proxyphylline, l'éphédrine et ses dérivés, les associations de caféine et de silanol, les composés d'origine naturelle contenant des bases xanthiques tels que les extraits de thé, de café, de guarana, de maté, de cacao ou de cola (Cola Nitida). La biocellulose favorise la diffusion d'un tel actif amincissant à travers la peau. De plus, la biocellulose est relativement simple à obtenir, chimiquement pure, ne nécessite pas de mettre en oeuvre des méthodes de synthèse chimique spécifiques et de surcroît est totalement biodégradable. L'invention a encore pour objet un ensemble comportant un substrat comportant de la biocellulose et une composition comportant un actif amincissant, de préférence l'un de ceux indiqués ci-dessus, cette composition étant conditionnée séparément et étant destinée à être appliquée sur le substrat et/ou le corps, avant l'application du substrat sur celui-ci. L'invention a encore pour objet un procédé de traitement amincissant, dans lequel on applique sur la peau un substrat comportant de la biocellulose et imprégné d'une composition contenant au moins un actif amincissant, de préférence l'un de ceux indiqués ci-dessus. On peut appliquer la composition sur le substrat, puis le substrat ainsi imprégné peut être appliqué sur la peau. On peut encore appliquer la composition sur la peau puis appliquer sur la peau le substrat. Many slimming compositions are known, for example having a draining action, that is to say reducing the retention of water in the epidermis and / or the superficial dermis, and / or acting by limiting the lipogenesis or promoting the lipolysis. There is a need to enhance the action of slimming compositions. According to one of its aspects, the invention achieves this through a slimming assembly comprising: a substrate comprising biocellulose; a composition comprising a slimming active agent impregnating the substrate. The slimming active agent is selected from caffeine and its derivatives, caffeine citrate, theophylline and its derivatives, theobromine, acefylline, aminophylline, chloroethylthéophylline, diprofylline, diniprophylline, etamiphylline and its derivatives. derivatives, etofylline, proxyphylline, ephedrine and its derivatives, combinations of caffeine and silanol, compounds of natural origin containing xanthine bases such as tea, coffee, guarana, mate extracts, cocoa or cola (Cola Nitida). Biocellulose promotes the diffusion of such a slimming active through the skin. In addition, biocellulose is relatively simple to obtain, chemically pure, does not require the use of specific chemical synthesis methods and in addition is completely biodegradable. The subject of the invention is also an assembly comprising a substrate comprising biocellulose and a composition comprising a slimming active agent, preferably one of those indicated above, this composition being packaged separately and intended to be applied to the substrate. and / or the body, before the substrate is applied thereto. The subject of the invention is also a slimming treatment method, in which a substrate comprising biocellulose and impregnated with a composition containing at least one slimming active agent, preferably one of those indicated above, is applied to the skin. . The composition can be applied to the substrate and then the thus impregnated substrate can be applied to the skin. It is also possible to apply the composition to the skin and then to apply the substrate to the skin.
L'invention a encore pour objet un ensemble de traitement des poches sous les yeux, comportant : - un substrat comportant de la biocellulose, - une composition imprégnant le substrat, contenant au moins un actif choisi parmi la caféine et ses dérivés, le citrate de caféine, la théophylline et ses dérivés, la théobromine, l' acéfylline, l'aminophylline, la chloroéthylthéophylline, le diprofylline, le diniprophylline, l'étamiphylline et ses dérivés, l'étofylline, la proxyphylline, l'éphédrine et ses dérivés, les associations de caféine et de silanol, les composés d'origine naturelle contenant des bases xanthiques tels que les extraits de thé, de café, de guarana, de cacao, de maté, de cola (Cola Nitida). The invention also relates to a set of treatment bags under the eyes, comprising: - a substrate comprising biocellulose, - a composition impregnating the substrate, containing at least one active ingredient selected from caffeine and its derivatives, the citrate of caffeine, theophylline and its derivatives, theobromine, acefylline, aminophylline, chloroethylthéophylline, diprofylline, diniprophylline, etamiphylline and its derivatives, etofylline, proxyphylline, ephedrine and its derivatives, combinations of caffeine and silanol, naturally occurring compounds containing xanthine bases such as tea, coffee, guarana, cocoa, mate, cola (Cola Nitida) extracts.
L'invention a encore pour objet un ensemble de traitement des poches sous les yeux, comportant : - un substrat comportant de la biocellulose, et -une composition contenant au moins un actif choisi parmi la caféine et ses dérivés, le citrate de caféine, la théophylline et ses dérivés, la théobromine, l'acéfylline, l'aminophylline, la chloroéthylthéophylline, le diprofylline, le diniprophylline, l'étamiphylline et ses dérivés, l'étofylline, la proxyphylline, l'éphédrine et ses dérivés, les associations de caféine et de silanol, les composés d'origine naturelle contenant des bases xanthiques tels que les extraits de thé, de café, de guarana, de cacao, de maté, de cola (Cola Nitida), cette composition étant conditionnée séparément et étant destinée à être appliquée sur le substrat et/ou le corps. L'invention a encore pour objet, selon un autre de ses aspects, un procédé de traitement cosmétique des poches sous les yeux, comportant l'étape consistant à appliquer sur les poches un substrat comportant de la biocellulose et imprégné d'une composition contenant au moins un actif choisi parmi la caféine et ses dérivés, le citrate de caféine, la théophylline et ses dérivés, la théobromine, l'acéfylline, l'aminophylline, la chloroéthylthéophylline, le diprofylline, le diniprophylline, l'étamiphylline et ses dérivés, l'étofylline, la proxyphylline, l'éphédrine et ses dérivés, les associations de caféine et de silanol, les composés d'origine naturelle contenant des bases xanthiques tels que les extraits de thé, de café, de guarana, de cacao, de maté, de cola (Cola Nitida). A la fois dans le cas du procédé de traitement amincissant et du procédé de traitement des poches, le substrat peut être laissé en place sur la peau pendant une durée supérieure ou égale à 5 minutes, par exemple une durée comprise entre 5 minutes et 12 heures, mieux une durée allant de 15 minutes à 8 heures. Substrat Le substrat comporte de la biocellulose. La biocellulose est un matériau obtenu par fermentation aérobie en milieu aqueux nutritif, de bactéries du genre Acetobacter (encore appelé Gluconacetobacter) (Z. Gromet-Elhanan, S. Hestrin, Synthesis of cellulose by Acetobacter Xylinum, J. Bacteriol. 85, 284-292, 1963 ; US 5 962 277). La principale espèce utilisée est Acetobacter xylinum, même si d'autres peuvent également produire de la biocellulose, par exemple Acetobacter pasteurianus. The invention also relates to a set of treatment bags under the eyes, comprising: - a substrate comprising biocellulose, and -a composition containing at least one active ingredient selected from caffeine and its derivatives, caffeine citrate, the theophylline and its derivatives, theobromine, acefylline, aminophylline, chloroethylthéophylline, diprofylline, diniprophylline, etamiphylline and its derivatives, etofylline, proxyphylline, ephedrine and its derivatives, caffeine combinations and silanol, compounds of natural origin containing xanthine bases such as tea, coffee, guarana, cocoa, mate, cola (Cola Nitida) extracts, this composition being packaged separately and being intended to be applied to the substrate and / or the body. The invention further relates, in another of its aspects, to a process for the cosmetic treatment of bags under the eyes, comprising the step of applying to the bags a substrate comprising biocellulose and impregnated with a composition containing the less an active ingredient selected from caffeine and its derivatives, caffeine citrate, theophylline and its derivatives, theobromine, acefylline, aminophylline, chloroethylthéophylline, diprofylline, diniprophylline, etamiphylline and its derivatives, etofylline, proxyphylline, ephedrine and its derivatives, combinations of caffeine and silanol, naturally occurring compounds containing xanthine bases such as tea, coffee, guarana, cocoa, mate, cola (Cola Nitida). In both the slimming treatment process and the pouch treatment method, the substrate may be left in place on the skin for a period of time greater than or equal to 5 minutes, for example a duration of between 5 minutes and 12 hours. , better a duration ranging from 15 minutes to 8 hours. Substrate The substrate contains biocellulose. Biocellulose is a material obtained by aerobic fermentation in a nutritious aqueous medium of bacteria of the genus Acetobacter (also called Gluconacetobacter) (Z. Gromet-Elhanan, S. Hestrin, Synthesis of cellulose by Acetobacter Xylinum, J. Bacteriol 85, 284- 292, 1963, US 5,962,277). The main species used is Acetobacter xylinum, although others may also produce biocellulose, for example Acetobacter pasteurianus.
Les conditions de culture de cette bactérie pour produire la biocellulose sont parfaitement connues, notamment de la publication Factors affecting the yield and properties of bacterial cellulose, A. Krystynowicz et al., J. Indus. Microbiol. Biotech. 29, 189-195, 2002. La biocellulose peut être utilisée sous forme pure ou sous une forme combinée à d'autres types de fibres, par exemple des fibres d'origine naturelle, par exemple des fibres issues du maïs, des fibres de chanvre, de lin, de coton, de jute, de kénaf, de raphia, de ramie, de Paja Toquilla, de sisal, de jonc, d'alfa, de phormium, de coco, de laine, de soie, de soja, d'abaca, de kumazasa, de plaqueminier, de kapok, de bardane, de céréales ou de bambou. Les fibres de biocellulose peuvent être libres ou liées entre elles et/ou liées à d'autres fibres. The culture conditions of this bacterium for producing biocellulose are well known, particularly from the publication Factors affecting the yield and properties of bacterial cellulose, A. Krystynowicz et al., J. Indus. Microbiol. Biotech. 29, 189-195, 2002. Biocellulose can be used in pure form or in a form combined with other types of fibers, for example fibers of natural origin, for example fibers derived from corn, hemp fibers , flax, cotton, jute, kenaf, raffia, ramie, paja toquilla, sisal, rush, alfalfa, phormium, coconut, wool, silk, soya, abaca, kumazasa, persimmon, kapok, burdock, cereal or bamboo. The biocellulose fibers may be free or bonded together and / or bound to other fibers.
La biocellulose peut être utilisée en feuille, obtenue par exemple en compactant une culture de fibres de biocellulose, après rinçage de celles-ci. L'épaisseur de la feuille est par exemple comprise entre 50 et 4000 m. Le substrat peut comporter au moins 10 % en masse, par rapport à la masse totale de substrat, de biocellulose. Le substrat peut aussi être constitué entièrement de biocellulose. Le substrat peut éventuellement être lié à un support, notamment un support permettant de le maintenir en place sur la peau. Le substrat peut se présenter en feuille par exemple et le dispositif de traitement comportant le substrat peut constituer un patch, un masque, une ceinture pour le corps ou un article vestimentaire. On a représenté à la figure 2 un ensemble comportant une bande 3 à refermer sur elle-même autour du corps, présentant des faces intérieure 6 et extérieure 7 ainsi que des moyens d'attache 30 tels que par exemple une fixation à crochets et boucles ou une fixation adhésive. The biocellulose may be used as a sheet, obtained for example by compacting a culture of biocellulose fibers after rinsing them. The thickness of the sheet is for example between 50 and 4000 m. The substrate may comprise at least 10% by weight, based on the total mass of substrate, of biocellulose. The substrate may also consist entirely of biocellulose. The substrate may optionally be bonded to a support, especially a support for holding it in place on the skin. The substrate may be a sheet for example and the treatment device comprising the substrate may constitute a patch, a mask, a belt for the body or an article of clothing. FIG. 2 shows an assembly comprising a band 3 to be closed on itself around the body, having inner and outer faces 6 and 7 as well as attachment means 30 such as for example a hook and loop fastener or an adhesive fixation.
La face intérieure 6 peut être définie par un substrat 8 en biocellulose et la face extérieure 7 par un support 9 qui peut être imperméable à la composition imprégnant la biocellulose, comme illustré à la figure 3. Le support peut éventuellement comporter un textile. Le substrat 8 peut être fixé de manière permanente ou non au support 9, ce qui peut par exemple permettre de remplacer un substrat usagé tout en conservant le support. Le substrat peut avoir reçu une imprégnation d'un adhésif, par exemple sous la forme de points ou d'une trame. The inner face 6 may be defined by a biocellulose substrate 8 and the outer face 7 by a support 9 which may be impermeable to the composition impregnating the biocellulose, as shown in FIG. 3. The support may optionally comprise a textile. The substrate 8 may be fixed permanently or not to the support 9, which may for example allow to replace a used substrate while retaining the support. The substrate may have received an impregnation of an adhesive, for example in the form of dots or a weft.
Le substrat en biocellulose peut être fourni à l'utilisateur déjà imprégné de la composition, l'utilisateur n'ayant qu'à l'appliquer sur la région à traiter. En variante, le substrat de biocellulose est imprégné au moment de l'utilisation en versant la composition contenant l'actif dessus ou en déposant la composition sur une 5 région de peau puis en appliquant le substrat sur cette région de peau. La région traitée avec la composition peut être par exemple une région des bras, des jambes ou du buste, comme illustré à la figure 4, ou du cou. Les poches sous les yeux peuvent encore être traitées. A titre d'illustration, on a représenté à la figure 5 un patch réniforme de traitement des poches sous les yeux. 10 Actif amincissant L'actif amincissant a par exemple une action drainante et/ou favorisant la lipolyse et/ou limitant la lipogenèse. Un tel actif peut notamment avoir une action drainante sur les poches sous les yeux, ce qui peut améliorer leur aspect. L'actif amincissant peut être choisi parmi la caféine et ses dérivés, le citrate de 15 caféine, la théophylline et ses dérivés, la théobromine, l'acéfylline, l'aminophylline, la chloroéthylthéophylline, le diprofylline, le diniprophylline, l'étamiphylline et ses dérivés, l'étofylline, la proxyphylline, l'éphédrine et ses dérivés, les associations de caféine et de silanol, les composés d'origine naturelle contenant des bases xanthiques tels que les extraits de thé, de café, de guarana, de maté, de cacao ou de cola (Cola Nitida). 20 Le ratio mtotal des actifs amincissants ou de traitement des poches/msubstrat peut être Supérieur Ou égal à 0,001, par exemple compris entre 0,001 et 0,05, où mtotal des actifs amincissants ou de traitement des poches désigne la masse totale en actif(s) amincissant(s) ou de traitement des poches et msubstrat désigne la masse du substrat. La composition imprégnant ou destinée à imprégner le substrat peut encore 25 comporter un actif choisi parmi les extraits végétaux de Garcinia Cambogia, les extraits de Bupleurum chinensis, les extraits de lierre grimpant (Hedera Helix), d'arnica (Arnica Montana L), de romarin (Rosmarinus officinalis L), de souci (Calendula officinalis), de sauge (Salvia officinalis L), de ginseng (Panax ginseng), de millepertuis (Hypericum Perforatum), de fragon (Ruscus aculeatus L), d'ulmaire (Filipendula ulmaria L), 30 d'orthosiphon (Orthosiphon Stamincus Benth), de bouleau (Betula alba), de cécropia et d'arganier, les extraits de ginkgo biloba, les extraits de prêles, les extraits d'escine, les complexes de phospholipide et de proanthocyanidines d'écorce de marron d'inde, les extraits de cangzhu, les extraits de chrysanthemum indicium, les sapogénines telles que la diosgénine ou l'hécogénine, leurs dérivés et les extraits naturels en contenant, en particulier le Wild Yam, les extraits des plantes du genre Armeniacea, Atractylodis Platicodon, Sinom-menum, Pharbitidis, Flemingia, les extraits de Coleus tels que C. The biocellulose substrate may be provided to the user already impregnated with the composition, the user having only to apply it to the region to be treated. Alternatively, the biocellulose substrate is impregnated at the time of use by pouring the active-containing composition thereon or by depositing the composition on a skin region and then applying the substrate to that skin region. The region treated with the composition may be for example a region of the arms, legs or bust, as shown in Figure 4, or neck. The bags under the eyes can still be treated. By way of illustration, FIG. 5 shows a reniform patch for the treatment of bags under the eyes. Slimming active The slimming active agent has for example a draining action and / or promoting lipolysis and / or limiting lipogenesis. Such an asset may especially have a draining action on the bags under the eyes, which can improve their appearance. The slimming active agent may be selected from caffeine and its derivatives, caffeine citrate, theophylline and its derivatives, theobromine, acefylline, aminophylline, chloroethylthéophylline, diprofylline, diniprophylline, etamiphylline and its derivatives, etofylline, proxyphylline, ephedrine and its derivatives, caffeine and silanol combinations, naturally occurring compounds containing xanthine bases such as tea, coffee, guarana, mate extracts , cocoa or cola (Cola Nitida). The mtotal ratio of the slimming or pouch / msubstrate active agents may be greater than or equal to 0.001, for example from 0.001 to 0.05, where mtotal slimming or bagging agents refers to the total mass of active ingredients (s). ) slimming (s) or bag treatment and msubstrate means the mass of the substrate. The impregnating or impregnating composition may further comprise an active ingredient selected from vegetable extracts of Garcinia Cambogia, extracts of Bupleurum chinensis, extracts of climbing ivy (Hedera Helix), arnica (Arnica Montana L), Rosemary (Rosmarinus officinalis L), Marigold (Calendula officinalis), Sage (Salvia officinalis L), Ginseng (Panax ginseng), St. John's Wort (Hypericum Perforatum), Butcher's broom (Ruscus aculeatus L), Ulmaria (Filipendula ulmaria) L), orthosiphon (Orthosiphon Stamincus Benth), birch (Betula alba), cecropia and argan, ginkgo biloba extracts, horsetail extracts, escin extracts, phospholipid and proanthocyanidins of chestnut bark, cangzhu extracts, chrysanthemum indicium extracts, sapogenins such as diosgenin or hecogenin, their derivatives and natural extracts containing them, in particular Wild Yam, extracts thereof s plants of the genus Armeniacea, Atractylodis Platicodon, Sinom-menum, Pharbitidis, Flemingia, extracts of Coleus such as C.
Forskohlii, C. blumei, C. esquirolii, C. scutellaroïdes, C. xanthantus et C. Barbatus, les extraits de Ballote, les extraits de Guioa, de Davallia, de Terminalia, de Barringtonia, de Trema, d'Antirobia, les extraits d'algues ou de phytoplancton tels que le rhodystérol ou l'extrait de Laminaria Digitata, l'algue skeletonema et les diatomées, les extraits de Dioscorée riche en diosgénine, provenant par exemple de racines d'igname sauvage. Forskohlii, C. blumei, C. esquirolii, C. scutellaroides, C. xanthantus and C. Barbatus, extracts of Ballot, extracts of Guioa, Davallia, Terminalia, Barringtonia, Trema, Antirobia, extracts algae or phytoplankton such as rhodysterol or Laminaria Digitata extract, skeletonema algae and diatoms, Dioscorea extracts rich in diosgenin, for example from wild yam roots.
Autres composés La composition imprégnant le substrat de biocellulose pourra contenir tous les adjuvants habituels utilisés dans le domaine cosmétique et/ou dermatologique, tels que des tensioactifs, des polymères, des huiles, des émollients, des épaississants, des conservateurs, des antioxydants, des solvants, des agents complexants, des parfums, des matières colorantes, cette liste n' étant pas limitative. La composition imprégnant la biocellulose peut se présenter sous diverses formes, en particulier sous forme d'une solution aqueuse ou alcoolique, sous forme anhydre telle que par exemple une huile ou un baume, ou encore d'émulsions H/E ou E/H ayant par exemple l'aspect d'une crème ou d'un lait ou sous forme de gels émulsionnés ou limpides, hydroalcooliques ou non, ou également sous forme particulaire (vésicules, capsules, micro et nano particules). Exemples comparatifs Une feuille de biocellulose est obtenue par fermentation statique en milieu aérobie d'une souche d'Acetobacter Xylinum (souche ATCC 23767) selon le procédé décrit dans Factors affecting the yield and properties of bacterial cellulose, A. Krystynowicz et al., J. Indus. Microbiol. Biotech. 29, 189-195, 2002, incorporé ici par référence. La masse de biocellulose obtenue après fermentation est rincée avec de l'eau distillée, lavée par une solution de soude diluée puis neutralisée par une solution d'acide acétique. Après rinçage avec de l'eau distillée, la masse de biocellulose est pressée afin d'obtenir une feuille d'environ 1 mm d'épaisseur. Other compounds The composition impregnating the biocellulose substrate may contain all the usual adjuvants used in the cosmetic and / or dermatological field, such as surfactants, polymers, oils, emollients, thickeners, preservatives, antioxidants, solvents , complexing agents, perfumes, dyestuffs, this list not being limiting. The composition impregnating the biocellulose may be in various forms, in particular in the form of an aqueous or alcoholic solution, in anhydrous form such as, for example, an oil or a balm, or O / W or W / O emulsions having for example the appearance of a cream or a milk or in the form of emulsified or limpid gels, hydroalcoholic or not, or also in particulate form (vesicles, capsules, micro and nano particles). Comparative Examples A biocellulose sheet is obtained by aerobic static fermentation of a strain of Acetobacter Xylinum (strain ATCC 23767) according to the method described in Factors affecting the yield and properties of bacterial cellulose, A. Krystynowicz et al., J. Indus. Microbiol. Biotech. 29, 189-195, 2002, incorporated herein by reference. The mass of biocellulose obtained after fermentation is rinsed with distilled water, washed with a dilute sodium hydroxide solution and then neutralized with a solution of acetic acid. After rinsing with distilled water, the mass of biocellulose is pressed to obtain a sheet about 1 mm thick.
La feuille de biocellulose est ensuite immergée dans 100 ml d'une solution aqueuse de caféine à 10 mg/ml pendant 16 heures. La feuille de cellulose est ensuite rapidement essuyée avec du papier absorbant pour enlever l'excédent de solution. The biocellulose sheet is then immersed in 100 ml of an aqueous caffeine solution at 10 mg / ml for 16 hours. The cellulose sheet is then quickly wiped with absorbent paper to remove excess solution.
Un rond de 3 cm' est découpé à l'emporte-pièce dans la feuille de biocellulose ainsi imprégnée puis placé sur une peau humaine excisée, dermatomée à environ 500 m et maintenue en survie sur une cellule de diffusion de Franz. Parallèlement, la solution de caféine est également placée sur la peau en cellule de Franz et sert de contrôle. La même quantité de caféine par cellule de Franz, soit 2,5 mg, est appliquée pour la biocellulose ou la solution seule. La concentration de caféine dans la phase réceptrice est mesurée par HPLC à 6h, 12het24h. On obtient les résultats donnés à la figure 1. On constate à tous les temps étudiés une concentration en caféine dans la phase 15 réceptrice environ 10 fois supérieure, quand la solution est imprégnée dans la feuille de biocellulose par rapport à la solution seule. La pénétration in vitro sur cellules de Franz de la caféine imprégnée dans la biocellulose a également été comparée à celle obtenue soit par une émulsion commerciale (Gel PerfectSlim , L'OREAL PARIS, contenant 1,5 % de caféine), soit par un patch 20 amincissant (patch hydrogel à base de polyacrylate de sodium contenant 1,5 % de caféine). On obtient les résultats suivants : Biocellulose Gel PerfectSlim Patch hydrogel Quantité de caféine dans la 33,79 3,25 5,07 1,79 17,21 6,40 phase réceptrice à 12 h (tg) On constate que le biocellulose induit in vitro une pénétration de caféine supérieure à celle obtenue soit par une émulsion soit par un patch hydrogel Exemples d'ensembles Produit décongestionnant, anti-poches pour le contour des yeux. Un patch en biocellulose en forme de contour des yeux est imprégné dans un rapport de masse 1 : 1 par une solution aqueuse à (0% de caféine. Le patch imprégné est mis en sachet puis il est stérilisé par autoclavage à 121 C pendant 20 minutes. Le patch est destiné à être appliqué pendant 20 minutes sur le dessous de l'oeil au niveau des poches pour obtenir un effet décongestionnant. Produit corps destiné à exercer une action amincissante, lipolytique et raffermissante. A 3 cm round is cut with a punch in the thus impregnated biocellulose sheet and placed on excised human skin, dermatomed at about 500 m and maintained in survival on a Franz diffusion cell. At the same time, the caffeine solution is also placed on the skin in Franz's cell and serves as a control. The same amount of caffeine per Franz cell, 2.5 mg, is applied for biocellulose or solution alone. The caffeine concentration in the receptor phase is measured by HPLC at 6h, 12het24h. The results given in FIG. 1 are obtained. In all the times studied, a caffeine concentration in the receiving phase is observed approximately 10 times higher, when the solution is impregnated in the biocellulose sheet with respect to the solution alone. The in vitro penetration into Franz cells of the caffeine impregnated into the biocellulose was also compared to that obtained either by a commercial emulsion (PerfectSlim Gel, L'OREAL PARIS, containing 1.5% of caffeine), or by a patch. slimming (hydrogel patch based on sodium polyacrylate containing 1.5% caffeine). The following results are obtained: Biocellulose Gel PerfectSlim Hydrogel patch Amount of caffeine in the 33.79 3.25 5.07 1.79 17.21 6.40 receptor phase at 12 h (tg) Biocellulose induces in vitro a caffeine penetration higher than that obtained either by an emulsion or by a hydrogel patch Examples of sets Decongestant product, anti-pockets for the eye contour. A biocellulose patch in the form of an eye contour is impregnated in a 1: 1 mass ratio by an aqueous solution containing 0% of caffeine.The impregnated patch is put in sachet then it is sterilized by autoclaving at 121 ° C. for 20 minutes. The patch is intended to be applied for 20 minutes on the underside of the eye at the level of the pockets to obtain a decongestant effect Body product intended to exert a slimming, lipolytic and firming action.
Une bande de biocellulose de 20cm x 40 cm est imprégnée dans un rapport de 1 : 0,5 en masse de la formule suivante (en %) : - CAFEINE : 2,0000 -TRIETHANOLAMINE : 0,2200 - EXTRAIT DE FIBRES DE SOJA HYDROLYSEES : 1,0000 - ACIDE SALICYLIQUE : 0,1900 - ALCOOL DENATURE : 20,0000 - EAU QSP -GLYCERINE : 3,0000 - HUILE DE RICIN HYDROGENEE : 0,6000 La bande de biocellulose imprégnée est destinée à être appliquée pendant 30 minutes sur les cuisses pour obtenir un effet amincissant et raffermissant. L'expression comportant un doit être comprise comme étant synonyme de comportant au moins un , sauf si le contraire est spécifié. A 20 cm x 40 cm biocellulose strip is impregnated in a ratio of 1: 0.5 by weight of the following formula (in%): CAFEIN: 2.0000 -TRIETHANOLAMINE: 0.2200 EXTRACT OF HYDROLYZED SOY FIBERS : 1.0000 - SALICYLIC ACID: 0.1900 - ALCOHOL DENATURE: 20.0000 - WATER QSP -GLYCERIN: 3.0000 - HYDROGENATED OIL OIL: 0.6000 The impregnated biocellulose strip is intended to be applied for 30 minutes on the thighs to obtain a slimming and firming effect. The expression containing one must be understood as being synonymous with at least one, unless the opposite is specified.
Claims (23)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0755532A FR2916971B1 (en) | 2007-06-06 | 2007-06-06 | SLIMMING ASSEMBLY. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0755532A FR2916971B1 (en) | 2007-06-06 | 2007-06-06 | SLIMMING ASSEMBLY. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2916971A1 true FR2916971A1 (en) | 2008-12-12 |
| FR2916971B1 FR2916971B1 (en) | 2009-08-21 |
Family
ID=39083236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0755532A Expired - Fee Related FR2916971B1 (en) | 2007-06-06 | 2007-06-06 | SLIMMING ASSEMBLY. |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2916971B1 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2390344A1 (en) | 2010-05-24 | 2011-11-30 | Nympheas International Biomaterial Corp. | Bacterial cellulose film and uses thereof |
| WO2013094077A1 (en) * | 2011-12-19 | 2013-06-27 | L'oreal | Cosmetic bio-cellulose sheet for lips |
| US20130244977A1 (en) * | 2010-10-26 | 2013-09-19 | Amorepacific Corporation | Cosmetic bio-cellulose mask pack sheet and method for manufacturing same |
| WO2017089005A1 (en) | 2015-11-25 | 2017-06-01 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
| CN106963706A (en) * | 2017-03-17 | 2017-07-21 | 广州欧慕生物科技有限公司 | A kind of eye-care compositions and medicine and eye-care product comprising said composition |
| FR3061012A1 (en) * | 2016-12-27 | 2018-06-29 | Deleo | PROCESS FOR REDUCING COLD SUBCUTANEOUS VOLUME USING ANTICELLULITE ACTIVE INGREDIENT |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3537003A1 (en) * | 1985-10-17 | 1987-04-23 | Manfred Raddatz | Selective redn. of unwanted fat deposits - by local application of bandage soaked in aq. ethanol |
| FR2670673A1 (en) * | 1990-12-21 | 1992-06-26 | Oreal | COSMETIC OR PHARMACEUTICAL COMPOSITION IN THE FORM OF A GEL WITH IMPROVED RHEOLOGICAL BEHAVIOR, IN PARTICULAR FOR MAINTAINING INCLUSIONS IN ITS BREAST. |
| DE29514849U1 (en) * | 1995-09-15 | 1995-11-16 | Weyergans, Rudolf, 52355 Düren | Cellulite patch |
| EP1201219A1 (en) * | 2000-10-27 | 2002-05-02 | L'oreal | Use of thermostabilising microcapsules for improving the activity or the penetration of cosmetic or pharmaceutical active agents |
| US20020127254A1 (en) * | 1998-06-25 | 2002-09-12 | Lavipharm Laboratories Inc. | Devices for local and systemic delivery of active substance and methods of manufacturing thereof |
| FR2856925A1 (en) * | 2003-03-17 | 2005-01-07 | Biochimie Appliquee Soc | A NEW COSMETIC OR PHARMACEUTICAL PATCH, ESPECIALLY DERMATOLOGICAL AND ITS APPLICATIONS |
-
2007
- 2007-06-06 FR FR0755532A patent/FR2916971B1/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3537003A1 (en) * | 1985-10-17 | 1987-04-23 | Manfred Raddatz | Selective redn. of unwanted fat deposits - by local application of bandage soaked in aq. ethanol |
| FR2670673A1 (en) * | 1990-12-21 | 1992-06-26 | Oreal | COSMETIC OR PHARMACEUTICAL COMPOSITION IN THE FORM OF A GEL WITH IMPROVED RHEOLOGICAL BEHAVIOR, IN PARTICULAR FOR MAINTAINING INCLUSIONS IN ITS BREAST. |
| DE29514849U1 (en) * | 1995-09-15 | 1995-11-16 | Weyergans, Rudolf, 52355 Düren | Cellulite patch |
| US20020127254A1 (en) * | 1998-06-25 | 2002-09-12 | Lavipharm Laboratories Inc. | Devices for local and systemic delivery of active substance and methods of manufacturing thereof |
| EP1201219A1 (en) * | 2000-10-27 | 2002-05-02 | L'oreal | Use of thermostabilising microcapsules for improving the activity or the penetration of cosmetic or pharmaceutical active agents |
| FR2856925A1 (en) * | 2003-03-17 | 2005-01-07 | Biochimie Appliquee Soc | A NEW COSMETIC OR PHARMACEUTICAL PATCH, ESPECIALLY DERMATOLOGICAL AND ITS APPLICATIONS |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2390344A1 (en) | 2010-05-24 | 2011-11-30 | Nympheas International Biomaterial Corp. | Bacterial cellulose film and uses thereof |
| US20130244977A1 (en) * | 2010-10-26 | 2013-09-19 | Amorepacific Corporation | Cosmetic bio-cellulose mask pack sheet and method for manufacturing same |
| US9226886B2 (en) * | 2010-10-26 | 2016-01-05 | Amorepacific Corporation | Method for manufacturing a cosmetic bio-cellulose mask pack sheet and use thereof |
| WO2013094077A1 (en) * | 2011-12-19 | 2013-06-27 | L'oreal | Cosmetic bio-cellulose sheet for lips |
| WO2017089005A1 (en) | 2015-11-25 | 2017-06-01 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
| US10736823B2 (en) | 2015-11-25 | 2020-08-11 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
| EP3900699A1 (en) | 2015-11-25 | 2021-10-27 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
| US11529433B2 (en) | 2015-11-25 | 2022-12-20 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
| FR3061012A1 (en) * | 2016-12-27 | 2018-06-29 | Deleo | PROCESS FOR REDUCING COLD SUBCUTANEOUS VOLUME USING ANTICELLULITE ACTIVE INGREDIENT |
| WO2018122535A1 (en) * | 2016-12-27 | 2018-07-05 | Deleo | Method for reducing a subcutaneous fat volume by means of cold using an anti-cellulite active ingredient |
| CN106963706A (en) * | 2017-03-17 | 2017-07-21 | 广州欧慕生物科技有限公司 | A kind of eye-care compositions and medicine and eye-care product comprising said composition |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2916971B1 (en) | 2009-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2980362A1 (en) | NOVEL COSMETIC USE OF ALBIZIA JULIBRISSIN EXTRACT AND CORRESPONDING TOPICAL COMPOSITION | |
| EP1038519B1 (en) | Use of at least a grafted silicone polymer as a tensioner | |
| FR2985425A1 (en) | NEW USE OF ZERUMBON | |
| FR2970868A1 (en) | PLANT ORIGIN EXTRACT, COMPOSITION CONTAINING THE SAME, PROCESS FOR OBTAINING BY VEGETABLE CULTURE AND USES IN THE COSMETIC, PHARMACEUTICAL AND COSMECEUTICAL FIELDS | |
| FR3034314B1 (en) | TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP LEATHER AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT FROM APIUM GRAVEOLENS | |
| FR2985424A1 (en) | NEW TOPICAL USE OF ZERUMBON | |
| FR2974297A1 (en) | NOVEL COSMETIC OR THERAPEUTIC USE OF GHK TRIPEPTIDE | |
| FR2940051A1 (en) | MULTI-COMPONENT ANTI-TRANSPIRANT AGENT COMPRISING TWO COMPONENTS CAPABLE OF COOPERATING AND METHOD FOR TREATING HUMAN TRANSPIRATION IN TWO STEPS | |
| FR2916971A1 (en) | Slimming kit, useful for slim the body to treat bags under the eyes, comprises substrate comprising biocellulose, and composition impregnating the substrate, comprising active slimming agent containing e.g. caffeine and its derivatives | |
| WO2007122343A1 (en) | Cosmetic rinsable mask type composition for skin care | |
| EP2642969A1 (en) | Cosmetic kit and use for improving the appearance of the skin | |
| FR2954143A1 (en) | Cosmetic treatment of sagging skin comprises applying at least one polymer to the skin, where the polymer is obtained by polymerization reaction of a tensing agent precursor having aryl ring with a catalyst system e.g. manganese salts | |
| EP1429720A2 (en) | Cosmetic composition for human skin and hair care | |
| FR2948564A1 (en) | USE OF N-HEXADECANOYL ISOLEUCINE FOR REGULATING THE ACTIVITY OF CELLS PRESENT IN ADIPOSE TISSUE OF HUMAN SKIN HYPODERM | |
| WO2013186465A1 (en) | Extract of cotton fibres and costmetic composition and use thereof for protecting, nourishing and hydrating the skin | |
| EP2833863A1 (en) | Novel oligosaccharide compounds and the cosmetic use thereof | |
| FR2988606A1 (en) | TOPICAL COMPOSITION COMPRISING BIOACTIVE SULPHATE OLIGOSACCHARIDES AND COSMETIC USES | |
| EP1541127B1 (en) | Use of modulators of aquaglyceroporins as slimming agents | |
| FR3051369A1 (en) | BEET HINT EXTRACTS, COMPOSITIONS AND USES | |
| EP1569614B1 (en) | Use of a cotton honeydew extract as active ingredient in or for preparing a cosmetic and/or pharmaceutical composition | |
| FR2953398A1 (en) | Cosmetic use of at least one saccharide polymer comprising at least one fucose unit, glucuronic acid unit and a glucose unit, as skin tightening agent, and for reducing, eliminating and/or smoothening wrinkles and/or lines of the skin | |
| FR2877221A1 (en) | COSMETIC COMPOSITION COMPRISING AN ACTIVE INGREDIENT AND A UREA COMPOUND | |
| FR3021539A1 (en) | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION COMPRISING A VEGETABLE EXTRACT AND A GENE ACTIVATOR | |
| FR3011742A1 (en) | NOVEL ACTIVE TO HOMOGENIZE LIP VERMILLON AND COSMETIC COMPOSITIONS COMPRISING SAME | |
| WO2011073941A1 (en) | Use of a polymer as an antioxidant agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |
Effective date: 20160229 |